We present a case of a 49-year-old man with a 20-year history of pneumoconiosis who was initially suspected to have pulmonary alveolar microlithiasis (PAM) and was admitted to our hospital in March ...

Ninety patients with advanced cancers who developed T-DXd‒related pneumonitis in two completed single-arm clinical trials were included. Three radiologists independently characterized the CT patterns ...

A year of research emphasizes the significance of collaboration, standardized approaches, and targeted therapies in rare pulmonary diseases. This article was originally published at HCP Live. It has ...

Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up. Test-retest repeatability for ...

Progressive fibrosing interstitial lung diseases (ILDs) encompass a wide range of diseases, including hypersensitivity pneumonitis, occupational diseases, granulomatous diseases, drug-induced diseases ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...